1). 88% Buy, up from 72% buy last week and 40% Buy, a month ago @Barchart.
2). Stay Long @ American Bulls.
3). $10.75 Price Target, from 5 analysts @Barrons.
4). $4.00 >$11.50 > $16.00 Price Targets @CNN Business.
5). HOLD Rating @ Zacks.
6). $11.22 TP mean rating, Chartmill.
Recent PYXS News
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 09/25/2024 08:08:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 09/13/2024 08:26:30 PM
- Pyxis Oncology to Participate in Two Upcoming Investor Conferences • GlobeNewswire Inc. • 08/29/2024 11:30:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:25:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2024 08:19:48 PM
- Pyxis Oncology Provides Corporate Update and Reports Financial Results for Second Quarter 2024 • GlobeNewswire Inc. • 08/14/2024 08:05:00 PM
- Pyxis Oncology to Participate in the BTIG Virtual Biotechnology Conference • GlobeNewswire Inc. • 07/29/2024 12:00:00 PM
- Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 06/28/2024 08:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/12/2024 08:17:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/10/2024 11:56:02 AM
- Pyxis Oncology Expands Board of Directors with Appointment of Michael A. Metzger • GlobeNewswire Inc. • 06/10/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 09:00:32 PM
- Pyxis Oncology to Participate in a Fireside Chat at the Jefferies Global Healthcare Conference • GlobeNewswire Inc. • 05/30/2024 11:30:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 12:00:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 11:55:35 AM
- Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024 • GlobeNewswire Inc. • 05/14/2024 11:30:00 AM
- Pyxis Oncology to Present at the RBC Capital Markets Global Healthcare Conference • GlobeNewswire Inc. • 05/09/2024 11:30:00 AM
- Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 03/28/2024 08:30:00 PM
- Pyxis Oncology Obtains $8 Million Payment for the Sale of Royalty Rights • GlobeNewswire Inc. • 03/27/2024 11:30:00 AM
- Pyxis Oncology Provides Corporate Update and Reports Financial Results for Fourth Quarter and Full Year 2023 • GlobeNewswire Inc. • 03/21/2024 11:30:00 AM
- Pyxis Oncology Expands Board of Directors with Appointment of Santhosh Palani, Ph.D., CFA • GlobeNewswire Inc. • 03/13/2024 12:00:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 03/08/2024 09:03:18 PM
- Pyxis Oncology to Present at Leerink Global Biopharma Conference 2024 • GlobeNewswire Inc. • 03/07/2024 09:30:00 PM
- Pyxis Oncology to Present New PYX-201, PYX-106 and PYX-102 Preclinical Data at AACR Annual Meeting • GlobeNewswire Inc. • 03/05/2024 09:45:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 12:02:43 PM
FEATURED Nightfood Signs Letter of Intent to Acquire Los Angeles Cooking School, Integrating Automation and Robotics with World-Class Culinary Training • Oct 1, 2024 8:30 AM
Integrated Ventures, Inc Reports Total 2024 Revenues Of $5,863,935 vs $3,862,849 for 2023. • INTV • Oct 1, 2024 9:00 AM
ZenaTech, Inc. (NASDAQ: ZENA) To Commence Trading Today • COOP • Oct 1, 2024 7:00 AM
Element79 Gold Corp secures loi for launching tailings reprocessing business in Arequipa, Peru • ELMGF • Oct 1, 2024 6:38 AM
BARRON'S COVE to Premier at the Hamptons International Film Festival • APHP • Sep 30, 2024 2:56 PM
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM